Buy Aurobindo Pharma; target of Rs 817: Geojit News News / News 7 years ago 544 Views comments Geojit has recommended buy rating on Aurobindo Pharma with a target price of Rs 817 in its research report dated 1 September 2017. Read more
News Royal Enfield announces Vietnam foray with flagship store in Ho Chi Minh City News / News - 7 years ago
News Equitas Small Finance Bank will not take IPO route, plans to rejig shareholding News / News - 5 years ago
Comments